Related Experiment Video
Updated: May 4, 2026

10:25
Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
4.5K
Trans-splicing with the group I intron ribozyme from Azoarcus
Summary
Group I introns are catalytic RNAs that can be engineered for trans-splicing. The smaller Azoarcus ribozyme shows efficient in vitro trans-splicing, but lower in vivo activity compared to Tetrahymena.
Area of Science:
- Molecular Biology
- Biochemistry
- RNA Catalysis
Background:
- Group I introns are ribozymes catalyzing RNA splicing.
- These ribozymes can be engineered from cis-splicing to trans-splicing for RNA modification.
- Previous trans-splicing research focused on the Tetrahymena thermophila 16S rRNA intron.
Purpose of the Study:
- To investigate the trans-splicing potential of the tRNA(Ile) group I intron ribozyme from Azoarcus.
- To compare the catalytic activity and efficiency of the Azoarcus ribozyme with the Tetrahymena ribozyme.
- To explore optimal designs for Azoarcus ribozyme trans-splicing in vitro and in vivo.
Main Methods:
- In vitro trans-splicing assays using substrate RNAs.
- Optimization of ribozyme 5' termini for trans-splicing.
- In vivo trans-splicing assays in Escherichia coli.
Main Results:
- The Azoarcus ribozyme, smaller and faster folding than Tetrahymena, favored similar splice sites in vitro.
- Both ribozymes exhibited comparable trans-splicing efficiency with optimized 5' termini.
- The Azoarcus ribozyme's optimal trans-splicing design mimicked its natural secondary structure, involving substrate-ribozyme base-pairing.
- In vivo, the Azoarcus ribozyme showed significantly lower splicing efficiency than the Tetrahymena ribozyme.
Conclusions:
- The Azoarcus ribozyme demonstrates efficient in vitro trans-splicing capabilities, with specific structural requirements for optimal activity.
- Its smaller size and faster folding present potential advantages for RNA manipulation.
- Despite high in vitro activity, its in vivo performance in E. coli is limited, suggesting challenges for cellular applications.
Related Concept Videos
RNA Splicing
53.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
53.3K
RNA Splicing
15.9K
15.9K
Alternative RNA Splicing
20.5K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
20.5K
Alternative RNA Splicing
4.2K
4.2K
Pre-mRNA Processing: RNA Splicing
5.6K
5.6K
Ribozymes
10.0K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
10.0K

